Last updated on October 2018

A Study to Assess the Safety Tolerability Pharmacokinetics Immunogenicity and Pharmacodynamics of JNJ-64179375 in Healthy Japanese Participants

Brief description of study

The primary purpose of this study is to assess the safety and tolerability of JNJ-64179375 in Part 1 and 2.

Clinical Study Identifier: NCT03080987

Contact Investigators or Research Sites near you

Start Over

Study Contact

Richmond Pharmacology Ltd
Surrey, United Kingdom